WACKER SILICONES
Sales at WACKER SILICONES decreased substantially in 2020. At €2.24 billion (2019: €2.45 billion), they were down 8.5 percent year over year. The decline was attributable to lower prices for standard silicones, to reduced volumes and to negative exchange-rate effects. In regional terms, WACKER SILICONES’ sales fell in the Americas, Asia and Europe.
EBITDA also decreased year over year. It fell 19.0 percent to €387.8 million (2019: €478.5 million) due to a significant fall in volumes and prices for standard silicones and to reduced volumes in general. The EBITDA margin was 17.3 percent (2019: 19.5 percent).
Capital expenditures dropped 49.9 percent year over year to €96.9 million (2019: €193.6 million). The funds were invested in new facilities, predominantly at sites in Germany. As of December 31, 2020, the division had 5,076 employees (Dec. 31, 2019: 5,267).
| Download XLS |
|
|
|
|
|
||||||
€ million |
|
2020 |
|
2019 |
|
2018 |
|
2017 |
|
2016 |
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Total sales |
|
2,244.0 |
|
2,453.0 |
|
2,499.6 |
|
2,200.2 |
|
2,001.1 |
EBITDA |
|
387.8 |
|
478.5 |
|
616.6 |
|
444.9 |
|
361.2 |
EBITDA margin (%) |
|
17.3 |
|
19.5 |
|
24.7 |
|
20.2 |
|
18.1 |
EBIT |
|
276.8 |
|
375.3 |
|
536.7 |
|
362.2 |
|
280.8 |
Capital expenditures |
|
96.9 |
|
193.6 |
|
222.7 |
|
142.8 |
|
88.6 |
R&D expenses |
|
60.2 |
|
65.0 |
|
60.9 |
|
58.6 |
|
53.7 |
Employees (December 31, number) |
|
5,076 |
|
5,267 |
|
5,114 |
|
4,737 |
|
4,566 |